HCA Healthcare: Assessing Valuation After 68% Rally and Strong Cash Flow Outlook in 2025

HCA Healthcare has a 68% rally year to date, with a 54.2% gain over the past year and 227.7% over five years. Despite a slight pullback, the stock remains undervalued, scoring a 5/6 valuation score. The discounted cash flow analysis estimates a fair value of $899.69 per share, implying a 44.4% discount to the current share price. The steady stream of positive sentiment around hospital operators and ongoing focus on procedure volumes support the positive sentiment.